News Center

• Oct. 31

  2023

  150 Party Organization Secretaries Visit CSPC

• Oct. 31

  2023

  VOLUNTARY ANNOUNCEMENT - BIVALENT COVID-19 mRNA VACCINE (SYS6006.32) OBTAINS CLINICAL TRIAL APPROVAL

• Oct. 30

  2023

  CSPC's GLP-1 Targeted Drug Project Approved as a Major Technology Innovation Project

• Oct. 30

  2023

  CSPC's SYHA1813 Research Findings Presented at ESMO

• Oct. 30

  2023

  CSPC Wins "Private Enterprises of Scientific and Technological Innovation" Title from ACFIC

• Oct. 26

  2023

  VOLUNTARY ANNOUNCEMENT - NBL-028 FOR THE TREATMENT OF ADVANCED TUMORS OBTAINS CLINICAL TRIAL APPROVAL IN CHINA